Neovasc to Participate in Stifel 2019 Healthcare Conference and Cannacord Genuity 13th Annual MedTech & Diagnostics Forum
06 nov. 2019 08h30 HE
|
Neovasc, Inc.
VANCOUVER, BC, Nov. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive...
Neovasc to Participate in the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019
30 oct. 2019 10h27 HE
|
Neovasc, Inc.
VANCOUVER, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral...
Neovasc to Announce Third Quarter 2019 Financial Results on Thursday, November 7, 2019
25 oct. 2019 07h00 HE
|
Neovasc, Inc.
VANCOUVER, Oct. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures
01 oct. 2019 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the...
AI-Powered Digital Health Company Eko Closes $20 Million Series B to Continue the Fight Against Heart Disease
25 sept. 2019 09h02 HE
|
Eko
San Francisco, CA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today announced it has secured $20...
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
12 sept. 2019 08h30 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 12, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting
11 sept. 2019 08h30 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 11, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019
29 août 2019 04h00 HE
|
Royal Philips
August 29, 2019 European debut of latest release of Philips EPIQ CVx cardiology ultrasound platform extends advanced automation capabilities to make exams faster and easier to conductPhilips...
Coronary Stents Market To Reach USD 15.37 Billion By 2026 | Reports And Data
26 août 2019 11h21 HE
|
Reports and Data
New York, Aug. 26, 2019 (GLOBE NEWSWIRE) -- High prevalence of coronary artery disease, changes in lifestyles and a rise in the geriatric population are the key factors contributing to the CAGR in...
Philips unveils HeartStart Intrepid with IntelliSpace Connect across Europe and select markets worldwide
19 août 2019 04h00 HE
|
Royal Philips
August 19, 2019 Enhanced communication and seamless data sharing capabilities augment clinical and operational efficiencies for patient assessment across emergency care settings Amsterdam,...